484 related articles for article (PubMed ID: 24042103)
1. Epidemiology of Candida blood stream infections: experience of a tertiary care centre in North India.
Chander J; Singla N; Sidhu SK; Gombar S
J Infect Dev Ctries; 2013 Sep; 7(9):670-5. PubMed ID: 24042103
[TBL] [Abstract][Full Text] [Related]
2. Candidemia in intensive care unit patients: a one year study from a tertiary care center in South India.
Giri S; Kindo AJ; Kalyani J
J Postgrad Med; 2013; 59(3):190-5. PubMed ID: 24029196
[TBL] [Abstract][Full Text] [Related]
3. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
[TBL] [Abstract][Full Text] [Related]
4. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Panizo MM; Reviákina V; Dolande M; Selgrad S
Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
[TBL] [Abstract][Full Text] [Related]
5. Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey.
Kuzucu C; Durmaz R; Otlu B; Aktas E; Gulcan H; Cizmeci Z
New Microbiol; 2008 Jul; 31(3):401-8. PubMed ID: 18843896
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing and the Clinical Laboratory Standards Institute BMD method for non-Candida albicans and non-C. tropicalis bloodstream isolates from eleven tertiary hospitals in São Paulo state, Brazil.
Purisco SU; Martins MA; Szeszs MW; Castro e Silva DM; Pukinskas SR; Bonfietti LX; Baez AA; Melhem MS
FEMS Yeast Res; 2012 Dec; 12(8):890-6. PubMed ID: 22883021
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and risk factors of candidemia in pediatric intensive care unit of a tertiary care children's hospital in Egypt.
Hegazi M; Abdelkader A; Zaki M; El-Deek B
J Infect Dev Ctries; 2014 May; 8(5):624-34. PubMed ID: 24820467
[TBL] [Abstract][Full Text] [Related]
8. Antifungal susceptibility testing of a 10-year collection of Candida spp. isolated from patients with candidemia.
Iatta R; Caggiano G; Cuna T; Montagna MT
J Chemother; 2011 Apr; 23(2):92-6. PubMed ID: 21571625
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period.
Kucukates E; Erturan Z; Susever S; Yegenoglu Y
APMIS; 2005 Apr; 113(4):278-83. PubMed ID: 15865609
[TBL] [Abstract][Full Text] [Related]
10. Changing trends of Candidemia and antifungal susceptibility pattern in a tertiary health care centre.
Chaudhary U; Goel S; Mittal S
Infect Disord Drug Targets; 2015; 15(3):171-6. PubMed ID: 26411557
[TBL] [Abstract][Full Text] [Related]
11. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
Shorr AF; Lazarus DR; Sherner JH; Jackson WL; Morrel M; Fraser VJ; Kollef MH
Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
[TBL] [Abstract][Full Text] [Related]
12. Species distribution and drug susceptibility of candida in clinical isolates from a tertiary care centre at Indore.
Pahwa N; Kumar R; Nirkhiwale S; Bandi A
Indian J Med Microbiol; 2014; 32(1):44-8. PubMed ID: 24399387
[TBL] [Abstract][Full Text] [Related]
13. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
Pfaller MA; Messer SA; Moet GJ; Jones RN; Castanheira M
Int J Antimicrob Agents; 2011 Jul; 38(1):65-9. PubMed ID: 21514797
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for candidemia-related mortality at a medical center in central Taiwan.
Cheng YR; Lin LC; Young TG; Liu CE; Chen CH; Tsay RW
J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249
[TBL] [Abstract][Full Text] [Related]
15. Changing epidemiology of candidemia in a medical center in middle Taiwan.
Hii IM; Chang HL; Lin LC; Lee YL; Liu YM; Liu CE; Chen CH; Cheng YR; Chang CY
J Microbiol Immunol Infect; 2015 Jun; 48(3):306-15. PubMed ID: 24113067
[TBL] [Abstract][Full Text] [Related]
16. Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999.
Cheng MF; Yu KW; Tang RB; Fan YH; Yang YL; Hsieh KS; Ho M; Lo HJ
Diagn Microbiol Infect Dis; 2004 Jan; 48(1):33-7. PubMed ID: 14761719
[TBL] [Abstract][Full Text] [Related]
17. [In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints].
Calışkan S; Keçeli Özcan S; Cınar S; Corakçı A; Calışkan E
Mikrobiyol Bul; 2011 Oct; 45(4):697-706. PubMed ID: 22090300
[TBL] [Abstract][Full Text] [Related]
18. Species distribution and antifungal susceptibility patterns of Candida spp. bloodstream isolates from a Brazilian tertiary care hospital.
Passos XS; Costa CR; Araújo CR; Nascimento ES; e Souza LK; Fernandes Ode F; Sales WS; Silva Mdo R
Mycopathologia; 2007 Mar; 163(3):145-51. PubMed ID: 17334813
[TBL] [Abstract][Full Text] [Related]
19. Fluconazole and itraconazole resistance of yeasts isolated from the bloodstream and catheters of hospitalized pediatric patients.
Giusiano G; Mangiaterra M; Garcia Saito V; Rojas F; Gómez V; Díaz MC
Chemotherapy; 2006; 52(5):254-9. PubMed ID: 16899974
[TBL] [Abstract][Full Text] [Related]
20. Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital.
Capoor MR; Nair D; Deb M; Verma PK; Srivastava L; Aggarwal P
Jpn J Infect Dis; 2005 Dec; 58(6):344-8. PubMed ID: 16377864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
